Related Experiment Video
Updated: Oct 28, 2025

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
The effect of early probiotic exposure on the preterm infant gut microbiome development
Yan Hui1, Birgitte Smith2,3, Martin Steen Mortensen4
1Department of Food Science, Faculty of Science, University of Copenhagen, Frederiksberg, Denmark.
Insights
Probiotic supplementation in preterm infants altered gut bacteria composition, reducing specific pathogens like Klebsiella. However, the overall gut microbiota progression during the neonatal period remained unchanged.
Area of Science:
- Microbiology
- Neonatal Medicine
- Gastroenterology
Background:
- Premature birth (<32 weeks gestation) increases neonatal morbidity and mortality risks.
- Probiotic use is suggested for preterm infants to support gut microbiota (GM) development, but optimal strains and doses are unclear.
- Gut microbiota plays a crucial role in infant health and development.
Purpose of the Study:
- To profile the gut microbiota development in preterm neonates before and after the introduction of probiotic supplementation.
- To investigate the impact of specific probiotic strains (Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12) on the preterm gut microbiome.
- To analyze changes in bacterial populations and the presence of opportunistic pathogens during the first 30 days of life.
Main Methods:
- Fecal samples were collected from two cohorts of preterm neonates (<30 weeks gestation) at 5, 10, and 30 days of life.
- One cohort (n=165) was before probiotic introduction; the second (n=87) received Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12.
- V3-V4 region 16S rRNA gene amplicon sequencing was used to profile the gut microbiota composition.
Main Results:
- Probiotic supplementation led to a distinct increase in L. rhamnosus and B. animalis in supplemented neonates.
- Gut microbiota progression showed a consistent pattern, dominated initially by Staphylococcus and Weissella, later by Veillonella, Enterococcus, and Enterobacteriaceae.
- Probiotic use significantly reduced Weissella, Veillonella spp., and the pathogen Klebsiella, alongside a gradual decrease in Citrobacter and Chryseobacterium.
Conclusions:
- Probiotic supplementation impacts the colonization of specific bacteria in preterm neonates.
- The overall longitudinal progression pattern of the gut microbiota in the neonatal period was not altered by probiotic intervention.
- Further research is needed to optimize probiotic strategies for preterm infants.
Abstract:
Premature birth, especially if born before week 32 of gestation, is associated with increased risk of neonatal morbidity and mortality. Prophylactic use of probiotics has been suggested to protect preterm infants via supporting a healthy gut microbiota (GM) development, but the suggested strains and doses vary between studies. In this study, we profiled the GM of 5, 10 and 30-day fecal samples from two cohorts of preterm neonates (born <30 weeks of gestation) recruited in the same neonatal intensive care unit. One cohort (n = 165) was recruited from September 2006 to January 2009 before probiotics were introduced in the clinic. The second cohort (n = 87) was recruited from May 2010 to October 2011 after introducing Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis ssp. lactis BB-12 supplementation policy. Through V3-V4 region 16S rRNA gene amplicon sequencing, a distinct increase of L. rhamnosus and B. animalis was found in the fecal samples of neonates supplemented with probiotics. During the first 30 days of life, the preterm GM went through similarly patterned progression of bacterial populations. Staphylococcus and Weissella dominated in early samples, but was gradually overtaken by Veillonella, Enterococcus and Enterobacteriaceae. Probiotic supplementation was associated with pronounced reduction of Weissella, Veillonella spp. and the opportunistic pathogen Klebsiella. Potential nosocomial pathogens Citrobacter and Chryseobacterium species also gradually phased out. In conclusion, probiotic supplementation to preterm neonates affected gut colonization by certain bacteria, but did not change the overall longitudinal bacterial progression in the neonatal period.Abbreviations: GM: Gut microbiota; ASV: Amplicon sequence variant; NEC: Necrotizing enterocolitis; DOL: Days of life; NICU: Neonatal intensive care unit; ESPGHAN: European Society for Pediatric Gastroenterology, Hepatology and Nutrition; Db-RDA: Distance-based redundancy analysis; PERMANOVA: Permutational multivariate analysis of variance; ANCOM: Analysis of compositions of microbiomes; LGG: Lacticaseibacillus (former Lactobacillus) rhamnosus GG; BB-12: Bifidobacterium animalis ssp. lactis BB-12; DGGE: Denaturing Gradient Gel Electrophoresis.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Related Concept Videos
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...